CTSL

Curated by Signal

Developer of regenerative medicines for pets and horses

Health Technologycelltherapysciences.co.uk

Overview

Developer of regenerative medicines for pets and horses. The company focuses on the development of stem cell treatments to treat osteoarthritis and musculoskeletal injuries such as tendon injuries in dogs, cats, and horses.

Key facts

Founded: 2014
Headquarters: Coventry, United Kingdom
Stage: Sign up to view
Industry: Health Technology

Business model

6 products and services: Sign up to view
Commercial model: Sign up to view

Contact

Email: Sign up to view
Phone: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

Sava
Provider of a biosensing platform for real time monitoring of health
Health TechnologyLondon, United Kingdom
OccuPain
Digital pain management tool for professionals
Health TechnologyLondon, United Kingdom
Envoke
Provider of an engagement platform for virtual instruments
Health TechnologyLeeds, United Kingdom

About CTSL

What does CTSL do?

Developer of regenerative medicines for pets and horses.

Where is CTSL headquartered?

CTSL is headquartered in Coventry, United Kingdom.

When was CTSL founded?

CTSL was founded in 2014.

Which sector is CTSL in?

CTSL operates in Health Technology.

Who are CTSL's competitors?

Companies similar to CTSL include Sava, OccuPain, and Envoke.